Skip to search formSkip to main contentSkip to account menu

Indinavir Sulfate

Known as: D-erythro-Pentonamide, 2,3,5-trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-, monohydrate, (1(1S,2R),5(S))-, sulfate (1:1) (salt), Indinavir, Sulfate (1:1), Indinavir Sulfate [Chemical/Ingredient] 
A synthetic antiviral agent. Indinavir selectively binds to the active site of human immunodeficiency virus (HIV) protease and inhibits its activity… 
National Institutes of Health

Related topics

Related topics

19 relations
Acquired Immunodeficiency SyndromeAstemizoleCYP3A7 protein, humanCisapride

Narrower (3)

CrixivanL-735 524MK-639

Broader (2)

IndinavirPyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified…
2006
2006
Electrochemical methods for determination of the protease inhibitor indinavir sulfate in pharmaceuticals and human serum.
Indinavir sulfate is an inhibitor of the human immunodeficiency virus (HIV) protease. The aim of this study was to determine… 
2005
2005
Validation and statistical analysis of two high performance liquid chromatography methods for the determination of indinavir sulfate raw material and capsules
Two high performance liquid chromatography (HPLC) methods for the quantitative determination of indinavir sulfate were tested… 
2003
2003
In‐vitro crystallization of indinavir in the presence of ritonavir and as a function of pH
The aim of this study was to investigate the in‐vitro crystallization of indinavir as a function of pH alteration and in the… 
2002
2002
CRIXIVAN ® ( INDINAVIR SULFATE ) CAPSULES
  • 2002
  • Corpus ID: 53004650
DESCRIPTION CRIXIVAN (indinavir sulfate) is an inhibitor of the human immunodeficiency virus (HIV) protease. CRIXIVAN Capsules… 
2000
2000
Identification of MK-944a: a second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitors.
Recent results from human clinical trials have established the critical role of HIV protease inhibitors in the treatment of… 
1999
1999
Trimethoprim/Sulfamethoxazole Does Not Affect the Steady‐State Disposition of Indinavir
This study evaluates the safety and potential pharmacokinetic interaction between indinavir and trimethoprim/sulfamethoxazole… 
Review
1997
Review
1997
[Urinary calculi and indinavir sulfate in patients with HIV infection. Apropos of 4 cases].
We report on 4 cases of urinary stone observed in patients treated with the drug Crixivan (Indinavir Sulfate) and review the… 
1996
1996
FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
: The Food and Drug Administration (FDA) approved two new protease inhibitors for treatment of AIDS. Ritonavir (Norvir) and… 
1996
1996
FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
The Food and Drug Administration (FDA) approved two new protease inhibitors for treatment of AIDS. Ritonavir (Norvir) and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)